Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Acute Coronary Syndrome: The beta-blocker of choice for heart attack patients | Repeat heart attacks | Empagliflozin
Wednesday, October 14, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Acute Coronary Syndromes

Top Stories

Why metoprolol should be the beta-blocker of choice for heart attack patients

While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Why metoprolol should be the beta-blocker of choice for heart attack patients

Share on Twitter Share on Facebook Share on Linkedin
While metoprolol was linked with limiting infarct size, two other beta-blockers—atenolol and propranolol—were not associated with such improvements.
READ MORE >

A return to normalcy: Resuming sexual activity soon after a heart attack boosts survival

The study tracked nearly 500 patients for more than two decades. 

READ MORE >
love romance couple sunset
Share on Twitter Share on Facebook Share on Linkedin

A return to normalcy: Resuming sexual activity soon after a heart attack boosts survival

Share on Twitter Share on Facebook Share on Linkedin
love romance couple sunset
The study tracked nearly 500 patients for more than two decades. 
READ MORE >

Women receive less aggressive care, and are more likely to die, after heart attack-related cardiogenic shock

Overall, researchers found, women were less likely to undergo coronary angiography, percutaneous coronary intervention and mechanical circulatory support than men.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Women receive less aggressive care, and are more likely to die, after heart attack-related cardiogenic shock

Share on Twitter Share on Facebook Share on Linkedin
Overall, researchers found, women were less likely to undergo coronary angiography, percutaneous coronary intervention and mechanical circulatory support than men.
READ MORE >

How flu vaccines may help limit COVID-19 among CVD patients

Ongoing studies related to seasonal influenza are suddenly getting more attention than before.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

How flu vaccines may help limit COVID-19 among CVD patients

Share on Twitter Share on Facebook Share on Linkedin
Ongoing studies related to seasonal influenza are suddenly getting more attention than before.
READ MORE >

Repeat heart attacks are down in the United States, especially among women

Recurrent coronary heart disease is also on the decline, according to a new analysis published in Circulation.

READ MORE >
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Share on Twitter Share on Facebook Share on Linkedin

Repeat heart attacks are down in the United States, especially among women

Share on Twitter Share on Facebook Share on Linkedin
In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.
Recurrent coronary heart disease is also on the decline, according to a new analysis published in Circulation.
READ MORE >

FDA fast-tracks empagliflozin for improving patient outcomes following a heart attack

The designation covers patients with and without diabetes. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

FDA fast-tracks empagliflozin for improving patient outcomes following a heart attack

Share on Twitter Share on Facebook Share on Linkedin
The designation covers patients with and without diabetes. 
READ MORE >

How to predict a CVD patient’s risk of total, colorectal and lung cancer

The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.

READ MORE >
Heart failure hospitalizations among young adults are getting more common and more expensive
Share on Twitter Share on Facebook Share on Linkedin

How to predict a CVD patient’s risk of total, colorectal and lung cancer

Share on Twitter Share on Facebook Share on Linkedin
Heart failure hospitalizations among young adults are getting more common and more expensive
The analysis was presented at ESC Congress 2020 and published in JACC: CardioOncology.
READ MORE >

In Case You Missed It

‘Selfies’ that save lives: AI detects heart disease using photographs

The AI algorithm was trained using photographs of more than 5,000 patients. 

READ MORE >
Selfie
Share on Twitter Share on Facebook Share on Linkedin

‘Selfies’ that save lives: AI detects heart disease using photographs

Share on Twitter Share on Facebook Share on Linkedin
Selfie
The AI algorithm was trained using photographs of more than 5,000 patients. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme